NDUFB3
protein-codingNADH:ubiquinone oxidoreductase subunit B3, the group of NADH:ubiquinone oxidoreductase supernumerary subunits
Gene summary
This gene encodes an accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which is the first enzyme in the electron transport chain of mitochondria. This protein localizes to the inner membrane of the mitochondrion as a single-pass membrane protein. Mutations in this gene contribute to mitochondrial complex 1 deficiency. Alternative splicing results in multiple transcript variants encoding the same protein. Humans have multiple pseudogenes of this gene. [provided by RefSeq, Mar 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~14.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032629
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032629
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0100133
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *NDUFB3* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of February 7, 2022. The *NDUFB3* gene encodes NADH:ubiquinone oxidoreductase (complex I) subunit B3, which is essential for complex I activity and assembly. Defects of this protein lead to complex I deficiency. The *NDUFB3* gene was first reported in relation to autosomal recessive mitochondrial disease in 2012 (PMID: 22277967). While various names have been given to the constellation of features seen in those with NDUFB3-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the NDUFB3 phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included two variants identified in eleven cases [10 cases had homozygous c.64T>C (p.Trp22Arg); the 11th case was compound heterozygous for c.64T>C (p.Trp22Arg) and c.208G>T (p.Gly70Ter)] in four publications (PMIDs: 22277967, 22499348, 27091925, 31000363). Features seen in these cases include intrauterine growth restriction, oligohydramnios, failure to thrive, short stature, metabolic acidosis, lactic acidosis, developmental delay, hypertrophic cardiomyopathy, arrhythmia (Wolff-Parkinson-White syndrome), pulmonary hypertension, liver disease, and dysmorphic features (prominent forehead, smooth philtrum, deep-set eyes, low-set ears). No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, functional alteration in patient cells, functional alteration in non-patient cells, and rescue in patient cells (PMIDs: 22277967, 22499348, 27626371, 27509854). In summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed since the first proposal of the association. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on February 7, 2022 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0032629
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032629
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Medical treatment (eg, riboflavin, ubiquinol) may be beneficial; Individuals may have cardiac involvement
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NDUFB3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002491.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 3 | ||||
| missense | 1 | 24 | 1 | 26 | ||
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 2 | 1 | 3 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 2 | 4 | 25 | 4 | 0 | 35 |
Highest pathogenic variant AF is 0.0016649372
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002482.1 | 2 | MANE Select | |
| Ensembl | ENSP00000237889.4 | 2 | MANE Select | |
| RefSeq | NP_001244031.1 | 2 | Standard | |
| Ensembl | ENSP00000410600.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Retrograde endocannabinoid signaling - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Huntington,s disease - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
Biological Process
- mitochondrial electron transport, NADH to ubiquinone
- mitochondrial respiratory chain complex I assembly
Molecular Function
- NADH dehydrogenase (ubiquinone) activity
Cellular Component
- mitochondrial inner membrane
- mitochondrial respiratory chain complex I
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000237889
- Coding exons
- 2
- Length
- 14318
- Individuals with no LoFs
- 125540
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 41
- Defined
- 125581
- p
- 0.000163
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.316 | 45 | 51.4 | 0.876 | 0.00000234 | 650 |
| Missense (PolyPhen) | 12 | 14.551 | 0.82471 | 176 | ||
| Synonymous | 0.982 | 12 | 17.2 | 0.699 | 7.42e-7 | 170 |
| Loss of Function | -1.10 | 6 | 3.72 | 1.61 | 1.57e-7 | 47 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00022 | 0.00022 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. {ECO:0000269|PubMed:27626371}.;
- Disease
- DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]: A disorder of the mitochondrial respiratory chain that causes a wide range of clinical manifestations from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:22499348, ECO:0000269|PubMed:27091925}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.688
- RVIS EVS
- 0.21
- RVIS percentile EVS
- 67.72
Essentials
- Essential (CRISPR)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |